Also trades as: TH.TO (TSX) · $vol 0M
THTX NASDAQ
Theratechnologies Inc.
1W: +0.0%
1M: +4.6%
3M: +5.9%
1Y: +173.4%
3Y: -63.9%
5Y: -61.8%
$3.39
Last traded 2025-10-02 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$86M
+5.0% ▲
5Y CAGR: +6.3%
Gross Profit
$65M
+5.3% ▲
5Y CAGR: +12.0%
Operating Income
$8M
+176.9% ▲
Net Income
-$8M
+65.3% ▲
EPS (Diluted)
$-0.17
+48.5% ▲
EBITDA
$7M
+177.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $66M | $70M | $80M | $82M | $86M |
| YoY Growth | +4.5% | +5.7% | +14.7% | +2.1% | +5.0% |
| Cost of Revenue | $27M | $23M | $26M | $20M | $20M |
| Gross Profit | $39M | $47M | $54M | $62M | $65M |
| Gross Margin | 59.3% | 66.7% | 67.2% | 76.0% | 76.2% |
| R&D Expenses | $18M | $28M | $37M | $30M | $17M |
| SG&A Expenses | $39M | $44M | $57M | $42M | $40M |
| Operating Expenses | $57M | $72M | $94M | $73M | $57M |
| Operating Income | -$18M | -$25M | -$40M | -$11M | $8M |
| Operating Margin | -27.2% | -36.1% | -49.8% | -13.0% | 9.5% |
| Interest Expense | $6M | $6M | $6M | $11M | $10M |
| Income Before Tax | -$23M | -$32M | -$47M | -$24M | -$6M |
| Tax Expense | $16K | $63K | $443K | $421K | $2M |
| Net Income | -$23M | -$32M | -$47M | -$24M | -$8M |
| Net Margin | -34.3% | -45.4% | -59.0% | -29.3% | -9.7% |
| EPS (Diluted) | $-0.29 | $-0.34 | $-0.50 | $-0.33 | $-0.17 |
| EBITDA | -$9M | -$17M | -$28M | -$9M | $7M |
| Shares Outstanding | 77M | 92M | 95M | 73M | 49M |